Transcutaneous oxygen measurement to evaluate drug effects

Area of Science:

• Perinatal Medicine
• Pharmacology
• Cardiorespiratory Physiology

Background:

• Evaluating drug effects in perinatal medicine relies on monitoring mother, fetus, and neonate.
• Noninvasive continuous measurement methods are crucial for assessing cardiorespiratory system responses.

Purpose of the Study:

• To highlight the utility of transcutaneous PO2 (tcPO2) monitoring in evaluating pharmacologic effects in perinatal medicine.
• To demonstrate how tcPO2 measurements enhance the assessment of drug impacts on maternal, fetal, and neonatal cardiorespiratory systems.

Main Methods:

• Utilized transcutaneous PO2 (tcPO2) electrode for noninvasive, continuous oxygen monitoring.
• Assessed cardiorespiratory parameters in mothers, fetuses, and newborns during various pharmacologic interventions.

Main Results:

• Documented respiratory depression and decreased PO2 with diazepam and meperidine during labor.
• Demonstrated beneficial effects of epidural anesthesia on maternal oxygen-cardiorespirograms.
• Showcased tcPO2's role in assessing drug effects (carticaine, fenoterol, theophylline, furosemide, indomethacin) and optimizing oxygen therapy in neonates.

Conclusions:

• Transcutaneous PO2 (tcPO2) monitoring is a valuable, noninvasive tool for assessing drug pharmacodynamics in perinatal care.
• tcPO2 measurements improve clinical evaluation of cardiorespiratory effects and guide therapeutic interventions for mother, fetus, and newborn.
• This technique offers a promising advancement for research in clinical pharmacology within obstetrics and neonatology.